Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP

被引:477
作者
Sabeh, F
Ota, I
Holmbeck, K
Birkedal-Hansen, H
Soloway, P
Balbin, M
Lopez-Otin, C
Shapiro, S
Inada, M
Krane, S
Allen, E
Chung, D
Weiss, SJ [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA
[2] Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA
[3] Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA
[4] Univ Oviedo, Inst Univ Oncol, Dept Bioquim, Oviedo 33006, Spain
[5] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1083/jcb.200408028
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
As cancer cells traverse collagen-rich extracellular matrix (ECM) barriers and intravasate, they adopt a fibroblast-like phenotype and engage undefined proteolytic cascades that mediate invasive activity. Herein, we find that fibroblasts and cancer cells express an indistinguishable pericellular collagenolytic activity that allows them to traverse the ECM. Using fibroblasts isolated from gene-targeted mice, a matrix metalloproteinase (MMP)-dependent activity is identified that drives invasion independently of plasminogen, the gelatinase A/TIMP-2 axis, gelatinase B, collogenase-3, collagenase-2, or stromelysin-1. In contrast, deleting or suppressing expression of the membrane-tethered MMP, MT1-MMP, in fibroblasts or tumor cells results in a loss of collagenolytic and invasive activity in vitro or in vivo. Thus, MT1-MMP serves as the major cell-associated proteinase necessary to confer normal or neoplastic cells with invasive activity.
引用
收藏
页码:769 / 781
页数:13
相关论文
共 60 条
[1]  
ARMSTRONG PB, 1982, CANCER RES, V42, P1826
[2]   Loss of collagenase-2 confers increased skin tumor susceptibility to male mice [J].
Balbín, M ;
Fueyo, A ;
Tester, AM ;
Pendás, AM ;
Pitiot, AS ;
Astudillo, A ;
Overall, CM ;
Shapiro, SD ;
López-Otín, C .
NATURE GENETICS, 2003, 35 (03) :252-257
[3]   Yeast nuclear extract contains two major forms of RNA polymerase II mediator complexes [J].
Liu, Y ;
Ranish, JA ;
Aebersold, R ;
Hahn, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7169-7175
[4]   A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen [J].
Benbow, U ;
Schoenermark, MP ;
Mitchell, TI ;
Rutter, JL ;
Shimokawa, K ;
Nagase, H ;
Brinckerhoff, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25371-25378
[5]  
BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140
[6]   Timeline - Matrix metalloproteinases: a tail of a frog that became a prince [J].
Brinckerhoff, CE ;
Matrisian, LM .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (03) :207-214
[7]   Impaired wound contraction in stromelysin-1-deficient mice [J].
Bullard, KM ;
Lund, L ;
Mudgett, JS ;
Mellin, TN ;
Hunt, TK ;
Murphy, B ;
Ronan, J ;
Werb, Z ;
Banda, MJ .
ANNALS OF SURGERY, 1999, 230 (02) :260-265
[8]   THE C-TERMINAL EXTRA-HELICAL PEPTIDE OF TYPE-I COLLAGEN AND ITS ROLE IN FIBRILLOGENESIS INVITRO [J].
CAPALDI, MJ ;
CHAPMAN, JA .
BIOPOLYMERS, 1982, 21 (11) :2291-2313
[9]  
CAULFIELD JB, 1979, LAB INVEST, V40, P364
[10]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572